Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Current Deferred Revenue (2020 - 2026)

PROCEPT BioRobotics has reported Current Deferred Revenue over the past 7 years, most recently at $13.7 million for Q1 2026.

  • Quarterly Current Deferred Revenue rose 39.83% to $13.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $13.7 million through Mar 2026, up 39.83% year-over-year, with the annual reading at $13.0 million for FY2025, 36.41% up from the prior year.
  • Current Deferred Revenue was $13.7 million for Q1 2026 at PROCEPT BioRobotics, up from $13.0 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $13.7 million in Q1 2026 and troughed at $1.4 million in Q1 2022.
  • The 5-year median for Current Deferred Revenue is $5.9 million (2024), against an average of $6.8 million.
  • Year-over-year, Current Deferred Revenue soared 188.23% in 2023 and then surged 33.5% in 2025.
  • A 5-year view of Current Deferred Revenue shows it stood at $2.9 million in 2022, then surged by 98.11% to $5.7 million in 2023, then surged by 69.11% to $9.6 million in 2024, then skyrocketed by 36.41% to $13.0 million in 2025, then rose by 5.01% to $13.7 million in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Current Deferred Revenue are $13.7 million (Q1 2026), $13.0 million (Q4 2025), and $10.7 million (Q3 2025).